Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
Eva Arnáiz,
Ove Almkvist,
Eva Arnáiz
Karolinska Institutet, Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research (NEUROTEC), Division of Geriatric Medicine, Huddinge University Hospital, Huddinge, Sweden;
Search for more papers by this authorOve Almkvist
Department of Psychology, Stockholm University, Sweden
Search for more papers by this authorEva Arnáiz,
Ove Almkvist,
Eva Arnáiz
Karolinska Institutet, Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research (NEUROTEC), Division of Geriatric Medicine, Huddinge University Hospital, Huddinge, Sweden;
Search for more papers by this authorOve Almkvist
Department of Psychology, Stockholm University, Sweden
Search for more papers by this authorEva Arnáiz/Ove Almkvist, Division of Geriatric Medicine, Huddinge University Hospital, B-84, S-141 86 Huddinge, Sweden
Tel.: +46 8585 82889
Fax: +46 8585 85470
e-mail: [email protected]
Abstract
Recent research has identified a transitional state between the cognitive changes of normal aging and Alzheimer's disease (AD), known as mild cognitive impairment (MCI). MCI patients experience memory loss to a greater extent than one would expect for age, yet they do not meet currently accepted criteria for clinically probable AD. An issue currently under investigation is whether MCI represents the preclinical stages of AD or a distinct and static cognitive aetiology. In an attempt to address this issue, the present investigations are adopting a convergent approach to the detection of preclinical AD, where multiple risk factors are considered when making a diagnosis. Currently, one of the most important tools when assessing early cognitive changes is neuropsychological evaluation. MCI subjects typically record neuropsychological performance between that of healthy older individuals and demented patients. Tests assessing new learning, delayed recall and attention/executive function seem to provide valuable information for screening and diagnosis of MCI and early AD if interpreted properly. Recommendations concerning methodological issues and the early management of neuropsychological MCI studies were made.
References
- 1 Petersen RC, Smith GE, Warring SC et al. Mild cognitive impairment: clinical characterisation and outcome. Arch Neurol 1999; 56: 303–8.
- 2 Tierney MC, Slazai JP, Snow GW et al. The prediction of Alzheimer's disease: the role of patients and informant perceptions of cognitive deficits. Arch Neurol 1996; 53: 423–7.
- 3 Bowen J, Teri L, Kukull W et al. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349: 763–5.
- 4 Dawe B, Procter A, Philpot M et al. Concepts of mild memory impairment in the elderly and their relationship to dementia: a review. Int J Geriatr Psychiatry 1992; 7: 473–9.
- 5 Wolf H, Grunwald M, Ecke GM et al. The prognosis of mild cognitive impairment in the elderly. J Neural Transm 1998; 54: 31–50.
- 6 Almkvist O, Bäckman L. Progression in Alzheimer's disease: sequencing of neuropsychological decline. Int J Geriatr Psychiatr 1993; 8: 755–63.
- 7 Petersen RC, Stevens JC, Ganguli M et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology 2001; 56: 1133–42.
- 8 Visser JV. Predictors of Alzheimer's type dementia in subjects with mild cognitive impairment. Thesis. Maastricht University, 2000.
- 9 Masur DM, Sliwinski M, Lipton RB et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427–32.
- 10 Weschler D. Weschler Adult Intelligence Scale (WAIS Manual). New York: The Psychological Corporation, 1955.
- 11 Jacobs DM, Sano M, Dooneief G et al. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957–62.
- 12 Goodglass H, Wingfield A, Hyde MR et al. Category specific dissociations in naming and recognition by aphasic patients. Cortex 1986; 22: 87–102.
- 13 Linn RT, Wolf PA, Bachman DL et al. The ‘preclinical phase’ of probable Alzheimer's disease. Arch Neurol 1995; 52: 485–90.
- 14 Elias MF, Beiseries A, Wolf PA et al. The preclinical phase of Alzheimer's disease. Arch Neurol 2000; 57: 808–13.
- 15 Wechsler D. Wechsler Adult Intelligence Scale Revised: Manual. New York: The Psychological Corporation, 1981.
- 16 Petersen RC. Mild cognitive impairment or questionable dementia? Arch Neurol 2000; 57: 643–4.
- 17 Blesa R, Adroer R, Santacruz P et al. High Apolipoprotein e epsilon 4 allele frequency in age-related memory decline. Ann Neurol 1996; 39: 548–51.
- 18 Small BJ, Fratiglioni L, Viitanen M et al. The course of cognitive impairment in pre-clinical Alzheimer's disease. Arch Neurol 2000; 57: 839–44.
- 19 Grober E. Memory impairment on free and cued recall selective reminding predicts dementia. Neurology 2000; 54: 827–31.
- 20 Grober E, Kawas C. Learning and retention in preclinical and early Alzheimer's disease. Psychol Aging 1997; 12: 183–8.
- 21 Buschke H. Cued recall in amnesia. J Clin Exp Neuropsychol 1984; 6: 433–40.
- 22 Fabrigoule C, Rouch I, Taberly A et al. Cognitive process in preclinical phase of dementia. Brain 1998; 121: 135–41.
- 23 Morris JC, Storandt M, Miller JP et al. Mild cognitive impairment represents early stage Alzheimer disease. Arch Neurol 2001; 58: 397–405.
- 24 Bozoki A, Giordani B, Heidebrink JL et al. Mild Cognitive Impairment predicts dementia in nondemented elderly patients with memory loss. Arch Neurol 2001; 58: 411–6.
- 25 Arnáiz E, Almkvist O, Ivnik RK et al. Mild cognitive impairment diagnosis: a cross national comparison of MCI samples. Submitted for publication.
- 26 Small BJ, Herlitz L, Bäckman L et al. Cognitive development in Alzheimer's disease: charting the decline process. Oxford: Elservier, 1997.
- 27 Howieson DB, Dame A, Camicioli R et al. Cognitive markers preceding Alzheimer's disease in the healthy oldest old. J Am Geriatr Soc 1997; 45: 584–9.
- 28 Devanand DP, Folz M, Gorlyn M et al. Questionable dementia: clinical course and predictors outcome. J Am Geriatr Soc 1997; 45: 321–8.
- 29 Flicker C, Ferris SG, Reisberg B et al. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41: 1006–9.
- 30 Flicker C, Ferris S, Reisberg B et al. A two-year longitudinal study of cognitive function in normal ageing and Alzheimer's disease. J Geriatr Psychiatry Neurol 1993; 6: 84–96.
- 31 Bäckman L, Small B. Influences of cognitive support on episodic remembering: tracing the process of loss from normal ageing to Alzheimer's disease. Psychol Ageing 1998; 12: 183–8.
- 32 Masur DM, Sliwinski M, Lipton RB et al. Predicting development of dementia in the elderly with selective reminding test. J Clin Exp Neuropsychol 1990; 12: 528–38.
- 33 Tuokko H, Vernon-Wilkinson R, Weir J et al. Cued recall and early identification of dementia. J Clin Exp Neuropsychol 1991; 13: 871–9.
- 34 Mortimer JA, Ebbit B, June SP et al. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992; 42: 1689–96.
- 35 Hänninen T, Hallikainen M, Koivisto K et al. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 1995; 43: 1007–15.
- 36 Rubin EH, Storandt M, Miller JP et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998; 55: 395–401.
- 37 Marra C, Silveri M, Gainotti G. Predictors of cognitive decline in the early stage of probable Alzheimer's disease. Dementia 1999; 11: 212–8.
- 38 Kluger A, Gianutsos J, Golomb J et al. Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimer's disease: diagnostic and differential diagnostic features. Int Psychogeriatr 1997 9(Suppl.): 307–16.
- 39 Chen P, Ratcliff G, Belle SG et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55: 1847–53.
- 40 Ritchie K, Artero S. Touchon. Classification criteria for mild cognitive impairment. A population-based validation study. Neurology 2001; 56: 37–42.
- 41 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), rev, 3rd edn. Washington, DC: American Psychiatric Association, 1987.
- 42 McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease. Neurology 1984; 34: 939–44.
- 43 Reisberg B, De Ferris SH, Leon et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136–9.
- 44 Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566–72.
- 45 Petersen RC, Smith G, Ivnik RJ et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. J Med Am Assoc 1997; 273: 1274–8.
- 46 Petersen RC, Smith G, Tangalos EC et al. Predictive value of APOE genotype in incipient Alzheimer's disease. Ann NY Acad Sci 1996; 802: 58–69.
- 47 Fratiglioni L, Grut M, Forsell Y et al. Clinical diagnosis of Alzheimer's disease and other dementias in a population surveys: agreement and causes of disagreement in applying DSM-III-R. Arch Neurol 1992; 49: 927–32.
- 48 Fratiglioni L, Viitanen M, Von Strauss E et al. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen project, Stockholm. Neurology 1997; 48: 132–8.
- 49 Crook TH, Bartus RT, Ferris SH et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical range. Report of a National Institute of Mental Health work group. Dev Neuropsychol 1986; 2: 261–76.
- 50 Ritchie K , Allard M, Huppert FA et al. Computerised cognitive examination of the elderly (ECO): the development of a neuropsychological examination for clinic and population use. Int J Geriatr Psychiatry 1993; 8: 899–914.
- 51 Weshcler D, Stone C. Weshler Memory Scale Manual. New York: The Psychological Corporation, 1973.
- 52 Rey A. L'examen clinique en psychologie. Paris: Presses Universitaire de France, 1959.
- 53 Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
- 54 Benton A, Hamsher K. Multilingual aphasia examination. Iowa City: University of Iowa, 1976.
- 55 Kaplan EF, Goodglass H, Weibtraub S. The Boston Naming Test, 2nd edn. Philadelphia, PA: Lea and Febriger, 1983.
- 56 Herlitz A, Small B, Fratiglioni L et al. Detection of mild dementia in community surveys: is it possible to increase the accuracy of our diagnostic instruments? Arch Neurol 1997; 54: 319–24.
- 57
Johansson B,
Zarit S.
Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old.
Int J Geriatr Psychiatr
1997; 12: 53–9.
10.1002/(SICI)1099-1166(199701)12:1<53::AID-GPS507>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 58 Arnáiz E, Blomberg M, Fernaeus S-E et al. Psychometric discrimination of Alzheimer's disease and mild cognitive impairment. Alzheimer's Reports 2000; 3: 97–103.
- 59 Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Arch Neurol 1989; 46: 383–6.
- 60 Morris JC, McKeel D, Storandt M et al. Very mild Alzheimer's disease: informant -based clinical, psychometric and pathological distinction from normal aging. Neurology 1991; 41: 469–78.
- 61 Welsh KA, Butterns N, Hughes JP et al. Detection and staging of dementia in Alzheimer's disease: use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992; 49: 448–52.
- 62
Bondi MW,
Monsch AU,
Galasko D et al.
Preclinical markers of dementia of the Alzheimer type.
Neuropsychol
1994; 8: 374–84.
10.1037/0894-4105.8.3.374 Google Scholar
- 63 Petersen RC, Smith G, Ivnik RJ et al. Memory function in very early Alzheimer's disease. Neurology 1994; 44: 867–72.
- 64 Smith GE, Petersen RC, Parisi JE et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol Cognition 1996; 3: 141–7.
- 65
Amkvist O,
Basun H,
Bäckman L et al.
Mild cognitive impairment – an early stage of Alzheimer's disease?
J Neural Transm
1998; 54: 21–9.
10.1007/978-3-7091-7508-8_3 Google Scholar
- 66 Cahn DA, Salmon DP, Butters N et al. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. J Int Neuropsychol Soc 1995; 1: 252–60.
- 67 Morris JC, Mohns R, Rogers H et al. Consortium to establish a registry of Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psyhopharmacol Bull 1988; 24: 641–52.
- 68 Jastak S, Wilkinson GS. The Wide Range Achievement Test Revised. Administration Manual. Wilmington, DE: Jastak Associates, 1984.
- 69
Ivnik RJ,
Malec JF,
Smith GR et al.
Mayo's older American normative studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97.
Clin Neuropsychologist
1992; 6: 1–104.
10.1080/13854049208401877 Google Scholar
- 70 Lezak M. Neuropsychological Assessment. New York: Oxford University Press, 1995.
- 71 Sliwinski M, Buschke H, Stewart W et al. The effect of dementia risk factors on comparative and diagnostic selective reminding norms. J Int Neuropsychol Soc 1997; 3: 317–26.
- 72 Sliwinski M, Lipton RB, Buschke H et al. The effect of preclinical dementia on estimates of normal cognitive functioning in ageing. J Gerontol B Psychol Sci Soc Sci 1996; 51 :217–25.
